FDA Approves RSV Vaccine to Pass Protection From Mother to Child
Published
Pfizer’s vaccine Abrysvo for pregnant women provides protection against RSV for newborns during their first six months. A vaccine that federal regulators approved on Monday could help make the most severe cases of a dangerous respiratory illness in infants a thing of the past.
#pfizer #abrysvo #rsv